The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved.
Bender
R
R
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000503:physiopathology* / Q000517:prevention & control; D018450:Disease Progression; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D008148:Lovastatin / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D012107:Research Design
D000924:Anticholesteremic Agents; D008148:Lovastatin